1. Home
  2. GRRR vs ELDN Comparison

GRRR vs ELDN Comparison

Compare GRRR & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorilla Technology Group Inc.

GRRR

Gorilla Technology Group Inc.

N/A

Current Price

$6.86

Market Cap

225.6M

Sector

Technology

ML Signal

N/A

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

N/A

Current Price

$1.99

Market Cap

219.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GRRR
ELDN
Founded
2001
2004
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
225.6M
219.4M
IPO Year
2022
2014

Fundamental Metrics

Financial Performance
Metric
GRRR
ELDN
Price
$6.86
$1.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
★ $32.83
$9.00
AVG Volume (30 Days)
★ 1.0M
915.3K
Earning Date
11-19-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 30.67
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$103.71
N/A
Revenue Next Year
$178.41
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.20
$1.35
52 Week High
$23.49
$4.49

Technical Indicators

Market Signals
Indicator
GRRR
ELDN
Relative Strength Index (RSI) 40.24 36.50
Support Level $6.65 N/A
Resistance Level $8.74 $3.14
Average True Range (ATR) 0.79 0.24
MACD 0.07 -0.07
Stochastic Oscillator 25.98 6.67

Price Performance

Historical Comparison
GRRR
ELDN

About GRRR Gorilla Technology Group Inc.

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments. Its expertise lies in revolutionizing urban operations, enhancing security, and optimizing digital transformation. It delivers pioneering products that integrate AI, deep learning, and edge computing to advance intelligent video surveillance, facial recognition, license plate recognition, post-event analytics, cybersecurity, and network intelligence.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical stage biotechnology company using immunology expertise in targeting the CD40 Ligand pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis. Its compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40L, a well-validated biological target that has broad therapeutic potential. It operates as one reportable segment, focused on the development of tegoprubart, to develop therapies to protect transplanted organs and prevent rejection, and to treat ALS.

Share on Social Networks: